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A B S T R A C T
 
Bone marrow is organized in specialized microenvironments known as ‘marrow niches’. 
These are important for the maintenance of stem cells and their hematopoietic progenitors 
whose homeostasis also depends on other cell types present in the tissue. Extrinsic factors, 
such as infection and inflammatory states, may affect this system by causing cytokine 
dysregulation (imbalance in cytokine production) and changes in cell proliferation and 
self-renewal rates, and may also induce changes in the metabolism and cell cycle. Known 
to relate to chronic inflammation, obesity is responsible for systemic changes that are 
best studied in the cardiovascular system. Little is known regarding the changes in the 
hematopoietic system induced by the inflammatory state carried by obesity or the cell 
and molecular mechanisms involved. The understanding of the biological behavior of 
hematopoietic stem cells under obesity-induced chronic inflammation could help elucidate 
the pathophysiological mechanisms involved in other inflammatory processes, such as 
neoplastic diseases and bone marrow failure syndromes.
© 2014 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. 
All rights reserved. 
Introduction
Bone marrow is an animal tissue with one of the highest 
cell proliferation rates. It gives rise to components of all 
hematopoietic and immune system lineages. In humans, 
approximately 1 × 1011  to 1 × 1012  mature blood cells are 
produced daily, due to the division and proliferation of a 
population of hematopoietic stem cells (HSCs), with a unique 
capacity for self-renewal and multilineage differentiation.1
The organization of bone marrow in specialized 
microenvironments, the ‘marrow niches,’ is important for the 
maintenance of hematopoietic stem and progenitor cells, as 
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well as their intramedullary localization and cell cycle phase.2  
Although the majority of HSCs were originally believed to be 
quiescent, many studies have demonstrated that these cells 
are actually cycling, although very slowly, suggesting a state of 
dormancy.3  They are activated for more intense proliferation 
and differentiation under stress conditions, when demands 
are higher (i.e. during infection) or for replacement of cells 
eliminated by cell death.2 In fact, many progenitors already 
committed to specific lineages appear to cycle actively. This 
condition strengthens the idea that the proliferation of HSCs 
and their progenitors is regulated by factors external to the 
cell itself, which must involve the action of different niches.4-6 
Osteoblasts, endothelial cells, macrophages and other 
more primitive mesenchymal cells exert, by mechanisms 
not yet fully elucidated, a direct effect on the control of 
hematopoiesis.7
The  identification  and distribution of bone marrow 
niches has been the subject of intense scientific debate. For 
example, HSCs have been shown to be in direct contact with 
a population of osteoblasts, which delimit the bone marrow 
surface. Osteoblasts are characterized by their fusiform shape 
and high expression of N-cadherin, called SNO cells (spindle-
shaped N-cadherin+ CD45- osteoplastic cells), which form 
the so-called ‘endosteal niche’.8 Many HSCs are also close 
to the sinusoidal endothelium, suggesting that endothelial 
cells could also create clusters for HSCs (the vascular niche).9 
Another recently discovered cell type that seems to play a key 
role in the maintenance of HSCs is the ‘CAR cell’ (CXCL12-
abundant reticular cell), a small population of reticular cells 
expressing high amounts of CXCL12.10  CXCR4, the CXCL12 
receptor, has been shown to be critical to maintain the HSCs 
pool and progenitor B cells in the bone marrow in direct 
contact with CAR cells, suggesting an important role of these 
cells in hematopoietic regulation .11 
Knowledge of the different rates of stem cell proliferation 
and their regulation by other cell types in homeostasis 
has raised questions regarding possible changes in these 
mechanisms and the relationship between infection and the 
hematopoietic niche along with HSC modulation. Factors such 
as the association between HSC exposure to toll-like receptor 
(TLR) ligands and osteoclasts maturation,12 in addition to the 
increase in granulocyte-colony stimulating factor (G-CSF) 
expression and the increase in the peripheral mobilization 
of HSCs,13 reinforce  the association between  infection and 
modulation of HSC biology.
In addition to the direct effects caused by the pathogens 
or pathogenic particles, changes in the clusters of HSCs and 
their biological activity in response to infection may also 
indirectly be mediated by pro-inflammatory cytokines. In a 
recent study, Chen et al. demonstrated that HSCs exposed to a 
combination of lipopolysaccharide-induced proinflammatory 
cytokines, Interleukin (IL)-6, tumor necrosis factor (TNF) and 
chemokine ligand 2 (CCL2), showed a decrease in the potential 
of marrow repopulation and long-term engraftment, while 
maintaining the proliferation potential.14 In a Mycobacterium 
avium infection model in mice, activation of HSCs was initiated 
by interferon-gamma (INF-g) signaling.15 However, high levels 
of INF-g  are known to be capable of inducing apoptosis in 
hematopoietic cells, leading to bone marrow hypocellularity. 
In fact, exposure of human CD34+ cells to INF-g leads to the 
expression of pro-apoptotic genes  in vitro16 and continuous 
exposure to INF-g  has also been related to a reduction in 
colony formation of human bone marrow cells in cultures.17 
The duration and conditions of exposure to interferon 
and other inflammatory cytokines  could  be crucial factors 
regulating the biological activity of HSCs. Different responses 
to inflammatory cytokines may explain, for example, 
the mechanisms that lead to some bone marrow failure 
syndromes.  It is because of this that these factors represent 
important areas for future scientific research.
Obesity and chronic inflammation and the 
hematopoietic system 
The association between obesity and low-grade chronic 
inflammation has been demonstrated in numerous 
studies.18-20 Inflammation has been implicated in the 
pathophysiology of many morbid complications observed in 
most obese individuals, through mechanisms that go beyond 
a positive caloric balance, such as the release of adipokines 
and interleukins.21  Originally considered a mechanism of 
energy reservoir, adipose tissue is now recognized as one of 
the body’s largest endocrine organs, secreting a variety of 
substances that exert multiple regulatory activities involving 
glucose homeostasis, immune function and metabolism.19 
Given the systemic nature of this process, it is plausible that 
changes in the hematopoietic and immune systems may 
occur due to obesity.
Experiments involving animal models have demonstrated 
that high-fat diet (HFD)-induced obesity is associated with 
high levels of acute-phase reactants and leukocytosis, in 
addition to higher bone marrow cellularity, mainly due to 
polymorphonuclear expansion.22 One possible mechanism 
postulated to explain the augment in  granulopoiesis is an 
increased production of G-CSF by bone marrow cells in the obese 
group compared to controls.23 Moreover, mesenchymal stem 
cells (MSC) of HFD rats express considerably higher amounts 
of nuclear Factor kappa β (NF-kβ) as well as tumor necrosis 
factor alpha (TNFα), IL-1 and IL-6, which can inhibit adipocyte 
differentiation of MSC thus shifting bone marrow differentiation 
towards osteoblasts. This mechanism could be responsible for 
niche alterations affecting marrow microenvironments and 
consequently destabilizing hematopoietic cell numbers and 
peripheral mobilization in the inflammatory state.22 
In humans, obesity is associated with a peripheral 
blood increase of white blood cell counts, correlating with 
increased levels of C-reactive protein and decreased IL-10.24,25 
Disturbances in erythropoiesis have also been described, 
including anemia and alterations in iron homeostasis.26 
Interestingly, increased levels of IL-6 and leptin induced by 
inflammation result in the release of hepcidin from the liver 
and adipose tissue.27,28 
Hepcidin is an important regulator of iron homeostasis, 
inhibiting iron absorption by enterocytes and the sequestration 
of iron by macrophages that result in restricted erythropoiesis 
leading to mild/moderate anemia.29 Obesity is associated 
with high levels of hepcidin, independently of the presence 
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of liver alterations,27 suggesting that the anemia experienced 
by obese individuals may be secondary to the inflammatory 
status (anemia of chronic disease), in addition to the direct 
effects of cytokines on the proliferation and differentiation of 
erythroid progenitors.
In fact, studies involving patients undergoing bariatric 
surgery as treatment of obesity have clarified the fact that 
anemia in this population cannot be explained solely on the 
basis of iron availability and nutritional status.30,31 Drygalski 
et al. assessed 1125 obese patients before and after bariatric 
surgery for the prevalence of anemia and the depletion of 
body iron stores. The baseline incidence of anemia was higher 
than expected and increased significantly after surgery as 
the overall iron bioavailability improved significantly with 
pronounced weight loss, possibly following the reduction in 
inflammation.31 Gastric bypass surgery was also associated 
with a generalized decrease in the white blood cell and platelet 
counts, although not clinically important.32 These findings 
suggest that generalized suppression of hematopoiesis might 
occur after surgery, revealing a possible hyperproliferative 
state triggered by inflammation in obese patients.
Bioenergetic organization of stem cells in obesity 
One of the striking features of the HSC niche is its low 
oxygen tension, yielding the term ‘hypoxic niche.’ This 
microenvironment of low O2 concentrations appears not only 
to be well tolerated by HSCs but also essential for keeping 
their self-renewal and differentiating properties.33-36 
Through mitochondrial metabolism, O2 generates reactive 
oxygen species (ROS) that, at increased levels, lead to cell 
dysfunction and aging, disrupting tissue homeostasis. The 
aberrant production of large quantities of ROS in mitochondria 
has been implicated in the pathophysiology of several chronic 
degenerative processes, such as Parkinson and Alzheimer’s 
diseases,37 and this seems to act in deleterious ways also 
in obesity, diabetes and metabolic syndrome.38 Thus, the 
distribution of stem cells in hypoxic niches with reduced 
ROS production seems clearly advantageous.39 Maintaining 
viability in a hypoxic environment, however, could require 
HSCs to have great metabolic adaptions; these mechanisms 
however are not yet fully known.
Cellular bioenergetic homeostasis is determined by the 
fraction of cellular adenosine triphosphate (ATP) produced 
by glycolysis or mitochondrial oxidative phosphorylation 
(OXPHOS). In some situations, as previously described in 
tumors, bioenergetic organization is different from normal 
cells’, wherein the method of ATP production switches 
progressively from oxidative phosphorylation to glycolysis, 
which is called the ‘Warburg effect’.40 This distinct metabolism 
results from the dysregulation of multiple oncogenes and 
tumor suppressor genes, whose final target is the glycolytic 
pathway,41 in addition to defects in the mitochondria itself. 
This mechanism may be responsible for better adaptation of 
tumor cells to microenvironments with chronic or intermittent 
hypoxia, in addition to reducing mitochondria-dependent cell 
death, facilitating invasion and metastasis.42 
Suppression of oxidative phosphorylation generates signals 
to adenosine monophosphate-activated protein kinases 
(AMPK), which reprogram cellular metabolism, stimulating 
glycolysis through increased cellular glucose uptake and 
activating 6-fosfofruto-2-kinase. Meanwhile, activated AMPK 
also inactivates enzymes responsible for ATP consumption 
including, for example, those involved in fatty acid and 
cholesterol synthesis.43 In addition to these effects, activation 
of AMPK also suppresses cell proliferation in normal and 
neoplastic tissues.44 
Increased AMPK after oxidative phosphorylation 
suppression is known to be transient. However, whether the 
maintenance of anaerobic conditions after normalization of 
AMPK could lead to the death of these cells, or whether any 
such mechanism would be only the initial part of an adaptive 
process by giving more advantage to these tissues, is not clear 
yet .45
An important mechanism of adaptation to hypoxia 
involves hypoxia-inducible factor 1 (HIF-1), a heterodimeric 
transcription factor composed of an O2-regulated subunit 
(HIF-1α) and a constitutional subunit (HIF-1β).46 The two 
subunits are present in all human and murine tissues and 
are activated by O2-dependent hydroxylases. The final action 
occurs primarily through modulation of transcription of other 
genes involved in the cell metabolism.47 
Another event that appears to be important for adaptation 
to hypoxia is the exchange of the regulatory subunit of the 
cytochrome c oxidase from cyclooxygenase COX4-1 to COX4-
2; the latter being activated by HIF-1. Other mitochondrial 
proteases are also activated by HIF-1, leading to enhanced 
degradation of COX4-1.48 This mechanism appears to be 
essential for the optimal function of cytochrome c oxidase in 
situations of hypoxia and to reduce ROS production.
Recently, a mechanism to minimize cell damage caused by 
excess ROS production, dependent on the action of uncoupling 
proteins (UCP) has been elucidated. Part of the proton 
gradient used to drive the synthesis of ATP is deflected from 
the membrane back into the mitochondrial matrix, thereby 
reducing the emission of ROS, this transport is carried out by 
UCP ‘uncoupling’ the oxidative phosphorylation process.49 
Three isoforms of UCP (UCP-1, -2 and -3) have been described 
and all appear to be activated by ROS molecules themselves, 
setting up a negative feedback loop.
Thus, we can speculate that obesity and its related 
deregulations in metabolism and inflammation may alter 
bone marrow niches and the energetic organization of marrow 
cells through pathways that have not been fully investigated 
until now.
Conclusion
Biologically, obesity is characterized by a state of chronic 
inflammation and its effects on the hematopoietic system, 
in particular on the stem cell compartment, are poorly 
understood. Therefore, further studies are needed to clarify the 
specific impact of this state at molecular and cellular levels, 
as well as the mechanisms involved. Long-term activation 
of hematopoietic stem cells during chronic inflammation 
may lead to the depletion of these cells or development of 
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functional defects, such as those seen in aplastic anemia. 
Therefore, this area of research may also provide new 
evidence to understand other situations involving chronic 
inflammation, such as normal aging, neoplastic diseases and 
bone marrow failure syndromes.
The evaluation of the proliferative and self-renewal 
potential of hematopoietic cells, the cytokine and 
hematopoietic growth factor profiles of obese individuals and 
the bioenergetic organization of stem cells in obesity are some 
key points for future investigation.
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